Bioavailabilty study of up to 5 different oral formulations of AZD5069

• Research type

  Research Study

• Full title

  An Open-label, Single Centre Relative Bioavailability Study With an Adaptive Design Comparing up to 5 Solid Oral AZD5069 Formulations After Single Dose Administration to Healthy Volunteers.

• IRAS ID

  139843

• Contact name

  Olufeyikemi Oluwayi

• Contact email

  Olufeyikemi.Oluwayi@quintiles.com

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2013-002953-30

• REC name

  Scotland A REC

• REC reference

  13/SS/0189

• Date of REC Opinion

  25 Nov 2013

• REC opinion

  Further Information Favourable Opinion